Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Phosphonoformate inhibits reverse transcriptase

B Sundquist, B Oberg

    The Journal of General Virology
    |November 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    The antiviral phosphonoformate (PFA) potently inhibits reverse transcriptase enzymes from various retroviruses, showing significantly greater activity than phosphonoacetate (PAA). This discovery offers new avenues for antiviral drug development against retroviral infections.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The patient enablement instrument for back pain: reliability, content validity, construct validity and responsiveness.

    Health and quality of life outcomes·2021
    Same author

    The ISCOM: an immunostimulating complex.

    Immunology today·2014
    Same author

    Lower extremity muscle strength in soccer players.

    Clinical biomechanics (Bristol, Avon)·2013
    Same author

    Tibial translation and muscle activation during rehabilitation exercises 5 weeks after anterior cruciate ligament reconstruction.

    Scandinavian journal of medicine & science in sports·2009
    Same author

    Parent's conceptions of intensive group training. The case of cerebral palsy.

    Disability and rehabilitation·2009
    Same author

    Predictive factors for arm pain, neck pain, neck specific disability and health after anterior cervical decompression and fusion.

    Acta neurochirurgica·2005
    Same journal

    ICTV Virus Taxonomy Profile: <i>Konkoviridae</i> 2026.

    The Journal of general virology·2026
    Same journal

    Variability and population structure of watermelon mosaic virus in zucchini crops in Poland.

    The Journal of general virology·2026
    Same journal

    Probing the sequence constraints for the stable incorporation of chimeric NSP1 segments into infectious rotaviruses.

    The Journal of general virology·2026
    Same journal

    Assessment of influenza virus and coronavirus tropism, replication competence and disease severity in <i>ex vivo</i> and <i>in vitro</i> cultures of the human respiratory tract.

    The Journal of general virology·2026
    Same journal

    GRHAL1, a novel lncRNA, regulates HIV-1 gene expression by modulating Tat- and Sp1-mediated HIV-1 LTR activation.

    The Journal of general virology·2026
    Same journal

    Hepatitis B virus X protein induces E6-associated protein-mediated proteasomal degradation of p53 phosphorylated at Ser-15.

    The Journal of general virology·2026
    See all related articles

    Area of Science:

    • Virology
    • Biochemistry
    • Antiviral Research

    Background:

    • Reverse transcriptases are key enzymes in retroviral replication.
    • Developing effective antiviral agents against retroviruses remains a critical challenge.

    Purpose of the Study:

    • To evaluate the antiviral potential of phosphonoformate (PFA).
    • To compare the inhibitory effects of PFA with phosphonoacetate (PAA) on various retroviral reverse transcriptases.

    Main Methods:

    • Cell-free system assays were used to test PFA and PAA activity.
    • Enzyme inhibition was assessed using various synthetic template/primers.
    • Dose-response curves and kinetic analyses were performed.

    Main Results:

    Related Experiment Videos

  • PFA significantly inhibited reverse transcriptase activity from avian and mammalian retroviruses.
  • PFA demonstrated 1000-fold greater potency than PAA against AMV and RMuLV polymerases.
  • Inhibition occurred regardless of divalent cation (Mg2+ or Mn2+) and affected both RNA- and DNA-dependent activities.

    • Conclusions:

    • Phosphonoformate is a potent inhibitor of retroviral reverse transcriptases.
    • PFA's mechanism involves immediate arrest of DNA synthesis.
    • PFA represents a promising candidate for antiviral therapy development.